Results 21 to 30 of about 1,034,274 (259)

Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.

PLoS ONE, 2020
Spondyloarthritis Research Consortium Canada (SPARCC) score is an effective magnetic resonance imaging (MRI) evaluation method for inflammation in axial spondyloarthritis.
Yupeng Huang, Yuehong Chen, Tao Liu, Sang Lin, Geng Yin, Qibing Xie   +5 more
doaj   +1 more source

The window of opportunity: A relevant concept for axial spondyloarthritis [PDF]

, 2014
The window of opportunity is a concept critical to rheumatoid arthritis treatment. Early treatment changes the outcome of rheumatoid arthritis treatment, in that response rates are higher with earlier disease-modifying anti-rheumatic drug treatment and ...
Robinson, P. C., Brown, Matthew A., Robinson, Philip C., Philip C Robinson, Brown, Matthew A, Matthew A Brown   +5 more
core   +2 more sources

Early axial spondyloarthritis [PDF]

Current Opinion in Rheumatology, 2010
To summarize recent advances in the classification of preradiographic axial spondyloarthritis (SpA).Inflammation in the sacroiliac joints precedes radiographic damage that is necessary to establish a diagnosis of ankylosing spondylitis (AS). Preradiographic axial SpA refers to patients with SpA who exhibit signs and symptoms of axial involvement, but ...
openaire   +2 more sources

Work Disability in Axial Spondyloarthritis [PDF]

Current Rheumatology Reports, 2020
AbstractPurpose of ReviewAxial spondyloarthritis (axSpA) is a chronic inflammatory disease that typically affects people of working age. Work-related outcomes are therefore important to study, both from an individual but also a societal perspective. Through this review of the literature, we explore the impact of axSpA on key work outcomes including ...
Nikiphorou, Elena, Ramiro, Sofia
openaire   +4 more sources

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

Frontiers in Immunology, 2021
Axial spondyloarthritis is a prevalent form of chronic arthritis which is related to psoriatic arthritis and skin psoriasis. TNF and IL-17A as well as IL-17F are key cytokines contributing to the pathobiology of this disease, as evidence by the ...
Dominique Baeten, Dominique Baeten, Iannis E. Adamopoulos   +2 more
doaj   +1 more source

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Annals of the Rheumatic Diseases, 2023
Objectives Axial spondyloarthritis (axSpA) is a complex disease with diverse manifestations, for which new treatment options are warranted. BE MOBILE 1 (non-radiographic (nr)-axSpA) and BE MOBILE 2 (radiographic axSpA (r-axSpA)) are double-blind, phase 3
D. M. van der Heijde, A. Deodhar, X. Baraliakos, Matthew A. Brown, H. Dobashi, M. Dougados, D. Elewaut, Alicia M. Ellis, C. Fleurinck, K. Gaffney, L. Gensler, N. Haroon, M. Magrey, W. Maksymowych, Alexander Marten, U. Massow, M. Oortgiesen, D. Poddubnyy, M. Rudwaleit, J. Shepherd-Smith, T. Tomita, F. E. Van den Bosch, T. Vaux, Huji Xu   +23 more
semanticscholar   +1 more source

Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort

Arthritis Research & Therapy, 2020
Background Sex differences with regard to clinical manifestations and response to tumor necrosis factor inhibitors (TNFi) have been delineated for the radiographic form of axial spondyloarthritis (axSpA).
Regula Neuenschwander, Monika Hebeisen, Raphael Micheroli, Kristina Bürki, Pascale Exer, Karin Niedermann, Michael J. Nissen, Almut Scherer, Adrian Ciurea   +8 more
doaj   +1 more source

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Annals of the Rheumatic Diseases, 2023
Ankylosing spondylitis (AS) is the historic term used for decades for the HLA-B27-associated inflammatory disease affecting mainly the sacroiliac joints (SIJ) and spine.
D. M. van der Heijde, A. Moltó, S. Ramiro, J. Braun, M. Dougados, F. V. van Gaalen, L. Gensler, R. Inman, R. Landewé, H. Marzo-Ortega, V. Navarro-Compán, Andri Phoka, D. Poddubnyy, M. Protopopov, J. Reveille, M. Rudwaleit, P. Sampaio-Barros, A. Sepriano, J. Sieper, F. E. Van den Bosch, I. E. van der Horst-Bruinsma, P. M. Machado, X. Baraliakos   +22 more
semanticscholar   +1 more source

Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Braun et al

Annals of the Rheumatic Diseases, 2023
We read with interest the letter by Braun pertaining to the 2022 update of the ASASEULAR recommendations for the management of axial spondyloarthritis (axSpA).
S. Ramiro, E. Nikiphorou, A. Sepriano, A. Ortolan, C. Webers, X. Baraliakos, R. Landewé, D. M. van der Heijde   +7 more
semanticscholar   +1 more source

Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

JMIR Research Protocols, 2023
BackgroundPatients with chronic inflammatory joint diseases such as axial spondyloarthritis have traditionally received regular follow-up in specialist health care to maintain low disease activity. The follow-up has been organized
Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik K Kristianslund, Siri Lillegraven, Gary J Macfarlane, Ellen Moholt, Sella A Provan, Joseph Sexton, Emil EK Thomassen, Annette De Thurah, Laure Gossec, Espen A Haavardsholm, Nina Østerås   +14 more
doaj   +1 more source